Cytosorbents Crp
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $8,612,795 | $9,894 | $9,786 | $8,668 |
Gross Profit | 5,281,615 | 6,502 | 6,570 | 5,311 |
EBITDA | -4,396,247 | -2,833 | -4,528 | -8,486 |
EBIT | -4,396,675 | -3,279 | -4,971 | -9,279 |
Net Income | -2,334,091 | -4,143 | -6,357 | -5,834 |
Net Change In Cash | 8,612,795 | 9,894 | 9,786 | 8,668 |
Free Cash Flow | -2,759 | -4,914 | -4,956 | -6,543 |
Cash | 5,685,328 | 8,458 | 8,608 | 14,131 |
Basic Shares | 54,453 | 54,306 | 54,262 | 48,624 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $36,349 | $29,360 | $40,109 | $39,453 |
Gross Profit | 22,392 | 15,404 | 29,061 | 28,400 |
EBITDA | -28,810 | -30,003 | -22,013 | -9,709 |
EBIT | -30,837 | -31,134 | -23,142 | -10,370 |
Net Income | -28,507 | -32,813 | -24,559 | -7,837 |
Net Change In Cash | 36,349 | 29,360 | 40,109 | 39,453 |
Cost of Revenue | -29,730 | -17,596 | 59,189 | |
Free Cash Flow | -22,591 | -34,689 | -18,286 | -7,289 |
Cash | 14,131 | 22,145 | 52,138 | 71,422 |
Basic Shares | 44,656 | 43,573 | 43,359 | 38,818 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.04 |
2024-06-30 | -$0.08 |
2024-03-31 | -$0.12 |
2023-12-31 | -$0.13 |
